Aarti Pharmalabs has inaugurated new state-of-the-art additional manufacturing block at Tarapur Unit 5, Maharashtra to expand its production capacity. The company has successfully obtained all the necessary permissions and approvals to start the facility. This block has a total capacity of 3600 TPA for Xanthine derivatives manufacturing, taking its total capacity to 9600 TPA, thereby placing it amongst top 3 Xanthine derivatives manufacturers globally. This new manufacturing block emphasizes a commitment towards the company’s growth and capability development to cater to large customers’ needs.
Aarti Pharmalabs (APL) (Formerly known as Aarti Organics) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.
